Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
better decrease » greater decrease (Expand Search), between decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 721 - 740 results of 21,342 for search '(( significantly ((better decrease) OR (teer decrease)) ) OR ( significant decrease decrease ))', query time: 0.51s Refine Results
  1. 721
    Phagocytosis of fluorescent latex beads (2 μm) by uninfected and infected PEMs, BMMs, and THP-1 (C) in static culture system.

    Phagocytosis of fluorescent latex beads (2 μm) by uninfected and infected PEMs, BMMs, and THP-1 (C) in static culture system. by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 722
    Macropinocytosis of pHrodo Red dextran by uninfected and infected PEMs, BMMs and THP-1) in static culture system.

    Macropinocytosis of pHrodo Red dextran by uninfected and infected PEMs, BMMs and THP-1) in static culture system. by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 723
    Phagocytosis of fluorescent latex beads (2 μm) by infected PEMs, BMMs and THP-1 in the three culture systems (static, slow flow rate 1.45 x 10− − 9 m/s and fast flow rate 1.23 x 10− − 7 m/s).

    Phagocytosis of fluorescent latex beads (2 μm) by infected PEMs, BMMs and THP-1 in the three culture systems (static, slow flow rate 1.45 x 10− − 9 m/s and fast flow rate 1.23 x 10... by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 724
    Macropinocytosis of pHrodo Red dextran by infected PEMs, BMMs and THP-1 at the three culture systems (static, slow flow rate 1.45 x 10− − 9 m/s and fast flow rate 1.23 x 10− − 7 m/s).

    Macropinocytosis of pHrodo Red dextran by infected PEMs, BMMs and THP-1 at the three culture systems (static, slow flow rate 1.45 x 10− − 9 m/s and fast flow rate 1.23 x 10− − 7 m/... by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 725
    Schematic overview of evaluation of the anti-leishmanial activity in static and flow culture systems [

    Schematic overview of evaluation of the anti-leishmanial activity in static and flow culture systems [ by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 726
    <i>In vitro</i> activity of chitosan solution and nanoparticles against <i>L. major</i> amastigotes in RPMI-1640 (pH = 6.5) at different flow rates.

    <i>In vitro</i> activity of chitosan solution and nanoparticles against <i>L. major</i> amastigotes in RPMI-1640 (pH = 6.5) at different flow rates. by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 727
    Dose-response curve of the activity of chitosan solution (A), blank chitosan-TPP nanoparticles (B), AmB loaded chitosan-TPP nanoparticles (C) and AmB solution (pure) (D) against L.

    Dose-response curve of the activity of chitosan solution (A), blank chitosan-TPP nanoparticles (B), AmB loaded chitosan-TPP nanoparticles (C) and AmB solution (pure) (D) against L. by Alaa Riezk (7037297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 728
    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It includes the number of participants in each group, frequency, intensity, and duration of chills, along with demographics such as gender, age, race, education level, and income. Statistical significance (p-value) is also provided for each category.

    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... by Felix Alexandre Schoeller (20988295)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 729
    <i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants.

    <i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. by Hala Tamim El Jarkass (16625309)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 730
    Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1.

    Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  11. 731
    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2.

    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  12. 732
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 733
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 734
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 735
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 736
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 737
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 738
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 739
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 740
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: